Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Braconi

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 20, 2009
Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cellsMolly Lang, Roger Henson, Chiara Braconi, et al.
Hepatology (Baltimore, Md.)|September 22, 2025
Evolving precision: Updates in targeted therapy for cholangiocarcinomaGiulia Tesini, Halima Ibrahim, Lorenza Rimassa, et al.
The American Journal of Pathology|December 27, 2024
Cholangiocarcinoma Targeted Therapies: Mechanisms of Action and ResistanceHaley Ellis, Chiara Braconi, Juan W Valle, et al.
Cells|April 3, 2020
Cholangiocarcinoma Disease Modelling Through Patients Derived OrganoidsFrancesco Amato, Colin Rae, Maria Giuseppina Prete, et al.
Cancers|January 11, 2025
Learning from Other Tumors: Pathways for Progress and Overcoming Challenges in CholangiocarcinomaGiulia Tesini, Chiara Braconi, Lorenza Rimassa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 19, 2018
Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implicationsMassimiliano Salati, Nicola Valeri, Andrea Spallanzani, et al.
Plos One|December 24, 2010
Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinomaChiara Braconi, Erica Swenson, Takayuki Kogure, et al.
Future Oncology (London, England)|November 15, 2016
Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?Maria C Previdi, Pietro Carotenuto, Domenico Zito, et al.
Journal of Hepatology|May 20, 2022
Metabolic reprogramming in cholangiocarcinomaChiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Gastroenterology|July 13, 2026
Molecular Subtypes of Cholangiocarcinoma and their Translational ImplicationsChiara Braconi, Colm J O'Rourke, Jesper B Andersen, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Liver International : Official Journal of the International Association for the Study of the Liver|February 20, 2009
Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cellsMolly Lang, Roger Henson, Chiara Braconi, et al.
Hepatology (Baltimore, Md.)|September 22, 2025
Evolving precision: Updates in targeted therapy for cholangiocarcinomaGiulia Tesini, Halima Ibrahim, Lorenza Rimassa, et al.
The American Journal of Pathology|December 27, 2024
Cholangiocarcinoma Targeted Therapies: Mechanisms of Action and ResistanceHaley Ellis, Chiara Braconi, Juan W Valle, et al.
Cells|April 3, 2020
Cholangiocarcinoma Disease Modelling Through Patients Derived OrganoidsFrancesco Amato, Colin Rae, Maria Giuseppina Prete, et al.
Cancers|January 11, 2025
Learning from Other Tumors: Pathways for Progress and Overcoming Challenges in CholangiocarcinomaGiulia Tesini, Chiara Braconi, Lorenza Rimassa, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 19, 2018
Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implicationsMassimiliano Salati, Nicola Valeri, Andrea Spallanzani, et al.
Plos One|December 24, 2010
Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinomaChiara Braconi, Erica Swenson, Takayuki Kogure, et al.
Future Oncology (London, England)|November 15, 2016
Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?Maria C Previdi, Pietro Carotenuto, Domenico Zito, et al.
Journal of Hepatology|May 20, 2022
Metabolic reprogramming in cholangiocarcinomaChiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Gastroenterology|July 13, 2026
Molecular Subtypes of Cholangiocarcinoma and their Translational ImplicationsChiara Braconi, Colm J O'Rourke, Jesper B Andersen, et al.
Pageof 10